Tag: Netherlands

Studies

• Effects of tamoxifen on cognitive function in patients with primary breast cancer Cite
  Luijendijk MJ, Buijs SM, Jager A, Koolen SLW, van der Wall E, Schagen SB, et al. Effects of tamoxifen on cognitive function in patients with primary breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2024; 10.1038/s41416-024-02914-1
• Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade Cite
  O’Leary RL, Duijm LEM, Boersma LJ, van der Sangen MJC, de Munck L, Wesseling J, et al. Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade. British Journal of Cancer. Springer Science and Business Media LLC; 2024; 131:852-859 10.1038/s41416-024-02785-6
• Effects of Different Combinations of Phytochemical-Rich Fruits and Vegetables on Chronic Disease Risk Markers and Gene Expression Changes: Insights from the MiBLEND Study, a Randomized Trial Cite
  DeBenedictis JN, Murrell C, Hauser D, van Herwijnen M, Elen B, de Kok TM, et al. Effects of Different Combinations of Phytochemical-Rich Fruits and Vegetables on Chronic Disease Risk Markers and Gene Expression Changes: Insights from the MiBLEND Study, a Randomized Trial. Antioxidants. MDPI AG; 2024; 13:915 10.3390/antiox13080915
• Subgroups of cognitively affected and unaffected breast cancer survivors after chemotherapy: a data-driven approach Cite
  Agelink van Rentergem JA, Lee Meeuw Kjoe PR, Vermeulen IE, Schagen SB. Subgroups of cognitively affected and unaffected breast cancer survivors after chemotherapy: a data-driven approach. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2023; 18:810-817 10.1007/s11764-022-01310-z
• Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma Cite
  Neppelenbroek SI, Geurts YM, Aleman BM, Lugtenburg PJ, Rademakers SE, de Weijer RJ, et al. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2024; 42:1903-1913 10.1200/jco.23.01386
• The Role of Magnetic Resonance Imaging in the Preoperative Staging and Treatment of Invasive Lobular Carcinoma Cite
  Willen LP, Spiekerman van Weezelenburg MA, Bruijsten AA, Broos PP, van Haaren ER, Janssen A, et al. The Role of Magnetic Resonance Imaging in the Preoperative Staging and Treatment of Invasive Lobular Carcinoma. Clinical Breast Cancer. Elsevier BV; 2024; 10.1016/j.clbc.2024.01.017
• Treatment and survival of patients diagnosed with high-risk HR+/HER2− breast cancer in the Netherlands: a population-based retrospective cohort study Cite
  Lammers S, Meegdes M, Vriens I, Voogd A, de Munck L, van Nijnatten T, et al. Treatment and survival of patients diagnosed with high-risk HR+/HER2− breast cancer in the Netherlands: a population-based retrospective cohort study. ESMO Open. Elsevier BV; 2024; 9:103008 10.1016/j.esmoop.2024.103008
• Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study Cite
  Naaktgeboren WR, Koevoets EW, Stuiver MM, van Harten WH, Aaronson NK, van der Wall E, et al. Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-023-07220-7
• The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer Cite
  Lammers SWM, Geurts SME, Van Hellemond IEG, Swinkels ACP, Smorenburg CH, Van Der Sangen MJC, et al. The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer. JNCI Cancer Spectrum. Oxford University Press (OUP); 2023; 10.1093/jncics/pkad092
• The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population Cite
  Alaeikhanehshir S, Schmitz RS, van den Belt-Dusebout AW, van Duijnhoven FH, Verschuur E, van Seijen M, et al. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07168-8
• Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis Cite
  Ploumen RAW, Claassens EL, Kooreman LFS, Keymeulen KBMI, van Kats MACE, Gommers S, et al. Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07012-z
• Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: Results of a pragmatic follow-up study Cite
  Naaktgeboren W, Koevoets E, Stuiver M, Harten Wv, Aaronson N, Wall EVd, et al. Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: Results of a pragmatic follow-up study. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3029690/v1
• 94MO The prognostic and predictive effect of BMI in postmenopausal HR+ breast cancer patients receiving (extended) endocrine therapy: DATA trial analysis Cite
  Lammers S, Geurts S, van Hellemond I, Swinkels A, Smorenburg C, van der Sangen M, et al. 94MO The prognostic and predictive effect of BMI in postmenopausal HR+ breast cancer patients receiving (extended) endocrine therapy: DATA trial analysis. ESMO Open. Elsevier BV; 2023; 8:101318 10.1016/j.esmoop.2023.101318
• The association of a combined healthy lifestyle with the risk of postmenopausal breast cancer subtypes in the Netherlands Cohort Study Cite
  van den Brandt PA. The association of a combined healthy lifestyle with the risk of postmenopausal breast cancer subtypes in the Netherlands Cohort Study. European Journal of Epidemiology. Springer Science and Business Media LLC; 2023; 10.1007/s10654-023-01005-4
• Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial Cite
  Zhang X, Gunda A, Kranenbarg EM, Liefers G, Savitha BA, Shrivastava P, et al. Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial. Breast Cancer Research. Springer Science and Business Media LLC; 2023; 25 10.1186/s13058-023-01643-2
• The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry Cite
  Meegdes M, Ibragimova KIE, Lobbezoo DJA, Vriens IJH, Kooreman LFS, Erdkamp FLG, et al. The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-021-06472-5
• Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis Cite
  van Maaren MC, Ávila AO, van Manen JG, Menke-Pluijmers MB, Veltman J, Bart J, et al. Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis. The Breast. Elsevier BV; 2021; 10.1016/j.breast.2021.07.020
• Adjuvant Aromatase Inhibitors or Tamoxifen following Chemotherapy for Perimenopausal Breast Cancer Patients Cite
  Dackus GM, Jóźwiak K, Sonke GS, van der Wall E, van Diest PJ, Siesling S, et al. Adjuvant Aromatase Inhibitors or Tamoxifen following Chemotherapy for Perimenopausal Breast Cancer Patients. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2021; 10.1093/jnci/djab091
• Adherence to the Mediterranean Diet and Overall Cancer Incidence: The Netherlands Cohort Study Cite
  Schulpen M, van den Brandt PA. Adherence to the Mediterranean Diet and Overall Cancer Incidence: The Netherlands Cohort Study. Journal of the Academy of Nutrition and Dietetics. Elsevier BV; 2021; 121:242-252 10.1016/j.jand.2020.07.025
• Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer Cite
  Dackus GMHE, Jóźwiak K, van der Wall E, van Diest PJ, Hauptmann M, Siesling S, et al. Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05978-8
• Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial Cite
  de Groot S, Lugtenberg RT, Cohen D, Welters MJP, Ehsan I, Vreeswijk MPG, et al. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nature Communications. Springer Science and Business Media LLC; 2020; 11 10.1038/s41467-020-16138-3
• Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer Cite
  van Uden DJP, van Maaren MC, Strobbe LJA, Bult P, van der Hoeven JJ, Siesling S, et al. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1201-5
• Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer Cite
  van Uden DJP, van Maaren MC, Bult P, Strobbe LJA, van der Hoeven JJM, Blanken-Peeters CFJM, et al. Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 176:217-226 10.1007/s10549-019-05219-7
• Animal foods and postmenopausal breast cancer risk: a prospective cohort study Cite
  Marcondes LH, Franco OH, Ruiter R, Ikram MA, Mulder M, Stricker BH, et al. Animal foods and postmenopausal breast cancer risk: a prospective cohort study. British Journal of Nutrition. Cambridge University Press (CUP); 2019; 122:583-591 10.1017/s0007114519000072
• Change in mammographic density across birth cohorts of Dutch breast cancer screening participants Cite
  Napolitano G, Lynge E, Lillholm M, Vejborg I, Gils CH, Nielsen M, et al. Change in mammographic density across birth cohorts of Dutch breast cancer screening participants. International Journal of Cancer. Wiley; 2019; 145:2954-2962 10.1002/ijc.32210
• Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study Cite
  van Maaren MC, de Munck L, Strobbe LJ, Sonke GS, Westenend PJ, Smidt ML, et al. Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study. International Journal of Cancer. Wiley; 2018; 144:263-272 10.1002/ijc.31914
• Associations of adult‐attained height and early life energy restriction with postmenopausal breast cancer risk according to estrogen and progesterone receptor status Cite
  Elands RJJ, Offermans NSM, Simons CCJM, Schouten LJ, Verhage BA, Brandt PA, et al. Associations of adult‐attained height and early life energy restriction with postmenopausal breast cancer risk according to estrogen and progesterone receptor status. International Journal of Cancer. Wiley; 2018; 144:1844-1857 10.1002/ijc.31890
• The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer Cite
  Poodt IG, Schipper R, Vugts G, Woensdregt K, van der Sangen M, Voogd AC, et al. The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer. European Journal of Surgical Oncology. Elsevier BV; 2018; 44:1714-1719 10.1016/j.ejso.2018.07.005
• Breast cancer–related deaths according to grade in ductal carcinoma in situ: A Dutch population–based study on patients diagnosed between 1999 and 2012 Cite
  van Maaren M, Lagendijk M, Tilanus-Linthorst M, de Munck L, Pijnappel R, Schmidt M, et al. Breast cancer–related deaths according to grade in ductal carcinoma in situ: A Dutch population–based study on patients diagnosed between 1999 and 2012. European Journal of Cancer. Elsevier BV; 2018; 101:134-142 10.1016/j.ejca.2018.07.003
• Alcohol drinking,ADH1BandADH1Cgenotypes and the risk of postmenopausal breast cancer by hormone receptor status: the Netherlands Cohort Study on diet and cancer Cite
  Hahn M, Simons CCJM, Weijenberg MP, van den Brandt PA. Alcohol drinking,ADH1BandADH1Cgenotypes and the risk of postmenopausal breast cancer by hormone receptor status: the Netherlands Cohort Study on diet and cancer. Carcinogenesis. Oxford University Press (OUP); 2018; 39:1342-1351 10.1093/carcin/bgy101
• Breast density and breast cancer-specific survival by detection mode Cite
  van der Waal D, Verbeek ALM, Broeders MJM. Breast density and breast cancer-specific survival by detection mode. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4316-7
• Tree nut, peanut, and peanut butter intake and risk of postmenopausal breast cancer: The Netherlands Cohort Study Cite
  van den Brandt PA, Nieuwenhuis L. Tree nut, peanut, and peanut butter intake and risk of postmenopausal breast cancer: The Netherlands Cohort Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2017; 29:63-75 10.1007/s10552-017-0979-7
• The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival Cite
  van Maaren MC, Bretveld RW, Jobsen JJ, Veenstra RK, Groothuis-Oudshoorn CG, Struikmans H, et al. The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival. British Journal of Cancer. Springer Science and Business Media LLC; 2017; 117:179-188 10.1038/bjc.2017.159
• Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer Cite
  Luiten JD, Voogd AC, Luiten EJT, Duijm LEM. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:307-314 10.1007/s10549-017-4412-4
• Patterns and predictors of first and subsequent recurrence in women with early breast cancer Cite
  Geurts YM, Witteveen A, Bretveld R, Poortmans PM, Sonke GS, Strobbe LJA, et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:709-720 10.1007/s10549-017-4340-3
• Inflammatory breast cancer in the Netherlands; improved survival over the last decades Cite
  van Uden DJP, Bretveld R, Siesling S, de Wilt JHW, Blanken-Peeters CFJM. Inflammatory breast cancer in the Netherlands; improved survival over the last decades. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 162:365-374 10.1007/s10549-017-4119-6
• Long-term Exposure to Fine Particulate Matter and Breast Cancer Incidence in the Danish Nurse Cohort Study Cite
  Andersen ZJ, Ravnskjær L, Andersen KK, Loft S, Brandt J, Becker T, et al. Long-term Exposure to Fine Particulate Matter and Breast Cancer Incidence in the Danish Nurse Cohort Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2016; 26:428-430 10.1158/1055-9965.epi-16-0578
• Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute Cite
  van der Leij F, van Werkhoven E, Bosma S, Linn SC, Rutgers EJ, van de Vijver MJ, et al. Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute. The Breast. Elsevier BV; 2016; 30:19-25 10.1016/j.breast.2016.08.004
• Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women Cite
  Elshof LE, Schaapveld M, Schmidt MK, Rutgers EJ, van Leeuwen FE, Wesseling J. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 159:553-563 10.1007/s10549-016-3973-y
• Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer Cite
  van den Belt-Dusebout AW, Spaan M, Lambalk CB, Kortman M, Laven JSE, van Santbrink EJP, et al. Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer. JAMA. American Medical Association (AMA); 2016; 316:300 10.1001/jama.2016.9389
• The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer Cite
  van Ramshorst MS, van der Heiden-van der Loo M, Dackus GMHE, Linn SC, Sonke GS. The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 158:361-371 10.1007/s10549-016-3878-9
• 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study Cite
  van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. The Lancet Oncology. Elsevier BV; 2016; 17:1158-1170 10.1016/s1470-2045(16)30067-5
• Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study Cite
  Doebar SC, van den Broek EC, Koppert LB, Jager A, Baaijens MHA, Obdeijn IAM, et al. Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 158:179-187 10.1007/s10549-016-3862-4
• Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study Cite
  van Roozendaal LM, Smit LHM, Duijsens GHNM, de Vries B, Siesling S, Lobbes MBI, et al. Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 156:465-472 10.1007/s10549-016-3757-4
• Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors Cite
  Boekel NB, Schaapveld M, Gietema JA, Russell NS, Poortmans P, Theuws JC, et al. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2016; 94:1061-1072 10.1016/j.ijrobp.2015.11.040
• Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01) Cite
  Charehbili A, Hamdy N, Smit V, Kessels L, van Bochove A, van Laarhoven H, et al. Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01). The Breast. Elsevier BV; 2016; 25:69-74 10.1016/j.breast.2015.10.005
• The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study Cite
  de Groot S, Vreeswijk MP, Welters MJ, Gravesteijn G, Boei JJ, Jochems A, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. Springer Science and Business Media LLC; 2015; 15 10.1186/s12885-015-1663-5
• The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors Cite
  van Gemert WA, Lanting CI, Goldbohm RA, van den Brandt PA, Grooters HG, Kampman E, et al. The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 152:155-162 10.1007/s10549-015-3447-7
• Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil Cite
  Daenen LGM, Cirkel GA, Houthuijzen JM, Gerrits J, Oosterom I, Roodhart JML, et al. Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil. JAMA Oncology. American Medical Association (AMA); 2015; 1:350 10.1001/jamaoncol.2015.0388
• Survival and relapse free period of 2926 unselected older breast cancer patients: A FOCUS cohort study Cite
  Kiderlen M, van de Water W, Bastiaannet E, de Craen AJ, Westendorp RG, van de Velde CJ, et al. Survival and relapse free period of 2926 unselected older breast cancer patients: A FOCUS cohort study. Cancer Epidemiology. Elsevier BV; 2015; 39:42-47 10.1016/j.canep.2014.11.007
• Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands Cite
  Janssen-Heijnen M, van Steenbergen L, Voogd A, Tjan-Heijnen V, Nijhuis P, Poortmans P, et al. Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands. Annals of Oncology. Elsevier BV; 2014; 25:64-68 10.1093/annonc/mdt424
• Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study Cite
  Otten J, Fracheboud J, den Heeten G, Otto S, Holland R, de Koning H, et al. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study. Annals of Oncology. Elsevier BV; 2013; 24:2501-2506 10.1093/annonc/mdt227
• Prevalence of lymphoedema more than five years after breast cancer treatment Cite
  Lopez Penha T, Slangen J, Heuts E, Voogd A, Von Meyenfeldt M. Prevalence of lymphoedema more than five years after breast cancer treatment. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2011; 37:1059-1063 10.1016/j.ejso.2011.09.001
• Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location Cite
  Vestjens JH, de Boer M, van Diest PJ, van Deurzen CH, van Dijck JA, Borm GF, et al. Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 131:645-651 10.1007/s10549-011-1771-0
• Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer Cite
  Truin W, Voogd AC, Vreugdenhil G, van der Sangen MJ, van Beek MW, Roumen RM. Influence of histology on the effectiveness of adjuvant chemotherapy in patients with hormone receptor positive invasive breast cancer. The Breast. Elsevier BV; 2011; 20:505-509 10.1016/j.breast.2011.05.005
• Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study Cite
  Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC, Coebergh JWW, Roumen RM, Nolthenius-Puylaert MCT, et al. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 127:195-203 10.1007/s10549-010-1086-6
• Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years Cite
  van der Sangen MJC, van de Wiel FMM, Poortmans PMP, Tjan-Heijnen VCG, Nieuwenhuijzen GAP, Roumen RMH, et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 127:207-215 10.1007/s10549-010-1110-x
• Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer Cite
  Tanis E, van de Velde C, Bartelink H, van de Vijver M, Putter H, van der Hage J. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10years in early stage breast cancer. European Journal of Cancer. Elsevier BV; 2012; 48:1751-1756 10.1016/j.ejca.2012.02.051
• Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age Cite
  van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJE, de Vries J, et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:643-651 10.1007/s10549-010-0805-3
• Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases Cite
  de Boer M, van Dijck JAAM, Bult P, Borm GF, Tjan-Heijnen VCG. Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2010; 102:410-425 10.1093/jnci/djq008
• Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial Cite
  Schilder CM, Seynaeve C, Beex LV, Boogerd W, Linn SC, Gundy CM, et al. Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1294-1300 10.1200/jco.2008.21.3553
• 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis Cite
  Jansen-van der Weide M, Greuter M, Jansen L, Oosterwijk J, Pijnappel R, Oudkerk M, et al. 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:239 10.1016/s1359-6349(10)70642-x
• Coffee and tea intake and risk of breast cancer Cite
  Bhoo Pathy N, Peeters P, van Gils C, Beulens JWJ, van der Graaf Y, Bueno-de-Mesquita B, et al. Coffee and tea intake and risk of breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 121:461-467 10.1007/s10549-009-0583-y
• Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer Cite
  Voorrips LE, Brants HA, Kardinaal AF, Hiddink GJ, van den Brandt PA, Goldbohm RA. Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2002; 76:873-882 10.1093/ajcn/76.4.873